Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
States one vial of Shingrix adjuvant was wasted due to an issue when withdrawing the solution from the vial; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate reconstitution technique in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate reconstitution technique (Verbatim: States one vial of Shingrix adjuvant was wasted due to an issue when withdrawing the solution from the vial). The outcome of the inappropriate reconstitution technique was not applicable. Additional Information: GSK Receipt date:17-SEP-2025 The reporter state one vial of Shingrix adjuvant was wasted due to a reconstitution error. During the withdrawal process, the needle was prematurely withdrawn from the vial. As a result, the healthcare professional inadvertently filled the needle with air instead of the solution. The batch number was not provided, and we are unable to contact the reporter.